Agency Information Collection Activities; Proposed Collection; Comment Request; Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Restaurant Facility Types, 73596-73599 [2014-29065]
Download as PDF
73596
Federal Register / Vol. 79, No. 238 / Thursday, December 11, 2014 / Notices
section E that currently asks ‘‘May we
give your name and contact information
to the company that makes the product
(manufacturer) to help them evaluate
the product?’’ to ‘‘If you do NOT want
your identity disclosed to the
manufacturer, place an ’X’ in this box.’’
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN
Number of
respondents
FDA Center/21 CFR section/FDA form
Center for Biologics Evaluation and Research/
Center for Drug Evaluationand Research:.
Form 3500 .....................................................
Form 3500A (§§ 310.305, 314.80, 314.98,
600.80, 1271.350).
Center for Devices and Radiological Health:.
Form 3500 .....................................................
Form 3500A (§ 803) .......................................
Center for Food Safety and Applied Nutrition:.
Form 3500 .....................................................
Form 3500A ...................................................
Center for Tobacco Products.
Form 3500 .....................................................
All Centers.
Form 3500B ...................................................
Total ...............................................................
VI. References
1. Kessler, D. A, ‘‘Introducing MEDWatch:
A New Approach to Reporting Medication
and Device Adverse Effects and Product
Problems,’’ Journal of the American Medical
Association, 269(21), June 2, 1993, pp. 2765–
2768.
Dated: December 5, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014–29064 Filed 12–10–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–2076]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Survey on the
Occurrence of Foodborne Illness Risk
Factors in Selected Restaurant Facility
Types
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:07 Dec 10, 2014
Jkt 235001
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Total
14,727
599
1
98
14,727
58,702
0.66 (40 minutes) .........
1.21 ...............................
9,720
71,029
5,233
2,277
1
296
5,233
673,992
0.66 (40 minutes) .........
1.21 ...............................
3,454
815,530
1,793
1,659
1
1
1,793
1,659
0.66 (40 minutes) .........
1.21 ...............................
1,183
2,007
39
1
39
0.66 (40 minutes) .........
26
13,750
1
13,750
0.46 (30 minutes) .........
6,325
........................
........................
........................
.......................................
909,274
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
a survey entitled, ‘‘Occurrence of
Foodborne Illness Risk Factors in
Selected Restaurant Facility Types
(2013–2022).’’
DATES: Submit either electronic or
written comments on the collection of
information by February 9, 2015.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
E:\FR\FM\11DEN1.SGM
11DEN1
Federal Register / Vol. 79, No. 238 / Thursday, December 11, 2014 / Notices
Survey on the Occurrence of Foodborne
Illness Risk Factors in Selected
Restaurant Facility Types (2013–2022)
(OMB Control Number 0910–0744)
I. Background
In 2013–2014, the U.S. Food and Drug
Administration (FDA) initiated a study
in two foodservice facility types: Full
service and fast food restaurants. The
study will span 10 years in its entirety
and aims to:
• Assist FDA with developing retail
food safety initiatives and policies
focused on the control of foodborne
illness risk factors—preparation
practices and employee behaviors most
commonly reported to the Centers for
Disease Control and Prevention as
contributing factors to foodborne illness
outbreaks at the retail level. (i.e. food
from unsafe sources, poor personal
hygiene, inadequate cooking, improper
holding/time and temperature, and
contaminated equipment/crosscontamination);
73597
• Identify retail food safety work plan
priorities and allocate resources to
enhance retail food safety nationwide;
• Track changes in the occurrence of
foodborne illness risk factors in retail
and foodservice establishments over
time; and
• Inform recommendations to the
retail and foodservice industry and
state, local, tribal, and territorial
regulatory professionals on reducing the
occurrence of foodborne illness risk
factors.
TABLE 1—DESCRIPTION OF THE FACILITY TYPES INCLUDED IN THE SURVEY
Facility type
Description
Full Service Restaurants ......
A restaurant where customers place their order at their table, are served their meal at the table, receive the service of the wait staff, and pay at the end of the meal.
A restaurant that is not a full service restaurant This includes restaurants commonly referred to as quick service
restaurants and fast casual restaurants.
mstockstill on DSK4VPTVN1PROD with NOTICES
Fast Food Restaurants ........
The statutory basis for FDA
conducting this study is derived from
the Public Health Service Act (42 U.S.C.
243, section 311(a)). Responsibility for
carrying out the provisions of the Act
relative to food protection was
transferred to the Commissioner of Food
and Drugs in 1968 (21 CFR 5.10(a)(2)
and (4)). Additionally, the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 301
et seq) and the Economy Act (31 U.S.C.
1535) require FDA to provide assistance
to other Federal, state, and local
government bodies.
The objectives of the study are to:
• Identify the foodborne illness risk
factors that are in most need of priority
attention during each data collection
period;
• Track trends in the occurrence of
foodborne illness risk factors over time;
• Examine potential correlations
between operational characteristics of
food establishments and the control of
foodborne illness risk factors;
• Examine potential correlations
between elements within regulatory
retail food protection programs and the
control of foodborne illness risk factors;
and
• Evaluate the impact of industry
food safety management systems in
controlling the occurrence of foodborne
illness risk factors.
The data from the 2013–2014
information collection in restaurants is
currently being analyzed by FDA. A
report summarizing the findings is
expected to be released in 2015. In order
to analyze trends, FDA is proposing to
conduct two additional data collections
in 2017–2018 and 2021–2022 using the
same methodology employed in the
2013–2014 data collection. This
methodology is described as follows.
VerDate Sep<11>2014
19:07 Dec 10, 2014
Jkt 235001
In order to obtain a sufficient number
of observations to conduct statistically
significant analysis, FDA will conduct
approximately 400 data collections in
each restaurant facility type during each
data collection period. This sample size
has been calculated to provide for
sufficient observations to be 95 percent
confident that the compliance
percentage is within 5 percent of the
true compliance percentage.
A geographical information system
database containing a listing of
businesses throughout the United States
will be used as the establishment
inventory for the data collections. FDA
will sample establishments from the
inventory based on the descriptions in
table 1. FDA does not intend to sample
operations that handle only
prepackaged food items or conduct low
risk food preparation activities. The
FDA Food Code contains a grouping of
establishments by risk, based on the
type of food preparation that is normally
conducted within the operation (Ref. 1).
The intent is to sample establishments
that fall under risk categories 2 through
4.
FDA has approximately 25 Regional
Retail Food Specialists (Specialists) who
will serve as the data collectors for the
10 year study. The Specialists are
geographically dispersed throughout the
United States and possess technical
expertise in retail food safety and a solid
understanding of the operations within
each of the facility types to be surveyed.
The Specialists are also standardized by
FDA’s Center for Food Safety and
Applied Nutrition personnel in the
application and interpretation of the
FDA Food Code (Ref. 1).
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Sampling zones will be established
which are equal to the 150 mile radius
around a Specialist’s home location.
The sample will be selected randomly
from among all eligible establishments
located within these sampling zones.
The Specialists are generally located in
major metropolitan areas (i.e.
population centers) across the
contiguous United States. Population
centers usually contain a large
concentration of the establishments
FDA intends to sample. Sampling from
the 150 mile radius sampling zones
around the Specialists’ home locations
provides three advantages to the study:
1. It provides a cross section of urban
and rural areas from which to sample
the eligible establishments.
2. It represents a mix of small,
medium, and large regulatory entities
having jurisdiction over the eligible
establishments.
3. It reduces overnight travel and
therefore reduces travel costs incurred
by the Agency to collect data.
The sample for each data collection
period will be evenly distributed among
Specialists. Given that participation in
the study by industry is voluntary and
the status of any given randomly
selected establishment is subject to
change, substitute establishments will
be selected for each Specialist for cases
where the restaurant facility is
misclassified, closed, or otherwise
unavailable, unable, or unwilling to
participate.
Prior to conducting the data
collection, Specialists will contact the
state or local jurisdiction that has
regulatory responsibility for conducting
retail food inspections for the selected
establishment. The Specialist will verify
E:\FR\FM\11DEN1.SGM
11DEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
73598
Federal Register / Vol. 79, No. 238 / Thursday, December 11, 2014 / Notices
with the jurisdiction that the facility has
been properly classified for the
purposes of the study and is still in
operation. The Specialist will also
ascertain whether the selected facility is
under legal notice from the state or local
regulatory authority. If the selected
facility is under legal notice, the
Specialist will not conduct a data
collection, and a substitute
establishment will be used. An
invitation will be extended to the state
or local regulatory authority to
accompany the Specialist on the data
collection visit.
A standard form will be used by the
Specialists during each data collection.
The form is divided into three sections:
Section 1—’’Establishment
Information;’’ Section 2—’’Regulatory
Authority Information;’’ and Section 3—
’’Foodborne Illness Risk Factor and
Food Safety Management System
Assessment.’’ The information in
Section 1—‘‘Establishment Information’’
of the form will be obtained during an
interview with the establishment owner
or person in charge by the Specialist
and will include a standard set of
questions.
The information in Section 2—
‘‘Regulatory Authority Information’’ will
be obtained during an interview with
the program director of the state or local
jurisdiction that has regulatory
responsibility for conducting
inspections for the selected
establishment. Section 3 includes three
parts: Part A for tabulating the
Specialists’ observations of the food
employees’ behaviors and practices in
limiting contamination, proliferation,
and survival of food safety hazards; Part
B for assessing the food safety
management being implemented by the
facility; and Part C for assessing the
frequency and extent of food employee
hand washing. The information in Part
A will be collected from the Specialists’
direct observations of food employee
behaviors and practices. Infrequent,
nonstandard questions may be asked by
the Specialists if clarification is needed
on the food safety procedure or practice
being observed. The information in Part
B will be collected by making direct
observations and asking follow up
questions of facility management to
obtain information on the extent to
which the food establishment has
developed and implemented food safety
management systems. The information
in Part C will be collected by making
VerDate Sep<11>2014
19:07 Dec 10, 2014
Jkt 235001
direct observations of food employee
hand washing. No questions will be
asked in the completion of Section 3,
Part C of the form.
FDA will collect the following
information associated with the
establishment’s identity: Establishment
name, street address, city, state, zip
code, county, industry segment, and
facility type. The establishment
identifying information is collected to
ensure the survey is not duplicative.
The establishment identifying
information is collected to ensure the
data collections are not duplicative.
Other information related to the nature
of the operation, such as seating
capacity and number of employees per
shift, will also be collected. Data will be
consolidated and reported in a manner
that does not reveal the identity of any
establishment included in the study.
FDA is working with the National
Center for Food Protection and Defense
to develop a Web-based platform in
FoodSHIELD to collect, store, and
analyze data for the Retail Risk Factor
Study. Once developed, this platform
will be accessible to state, local,
territorial, and tribal regulatory
jurisdictions to collect data relevant to
their own risk factor studies. FDA is
currently transitioning from the manual
entry of data to the use of hand-held
technology. FDA will be pilot testing the
use of hand-held technology during its
2015–2016 risk factor study data
collection in institutional foodservice
and retail food stores, with the goal to
have it fully implemented for the 2017–
2018 data collection in restaurants.
When a data collector is assigned a
specific establishment, he or she will
conduct the data collection and enter
the information into the Web-based data
platform. The interface will support the
manual entering of data, as well as the
ability to upload a fillable PDF.
The burden for the 2017–2018 data
collection is as follows. For each data
collection, the respondents will include:
(1) The person in charge of the selected
restaurant facility (whether it be a fast
food or full service restaurant); and (2)
the program director (or designated
individual) of the respective regulatory
authority. In order to provide the
sufficient number of observations
needed to conduct a statistically
significant analysis of the data, FDA has
determined that the same number of
data collections will be required in each
of the two restaurant facility types as
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
was required in the 2013–2014 data
collection (i.e. 400). Therefore, the total
number of responses for restaurants will
be 1,600 (400 data collections × 2
facility types × 2 respondents per data
collection).
The burden associated with the
completion of Sections 1 and 3 of the
form is specific to the persons in charge
of the selected facilities. It includes the
time it will take the person in charge to
accompany the data collector as he or
she completes Sections 1 and 3 of the
form. The burden related to the
completion of Section 2 of the form is
specific to the program directors (or
designated individuals) of the respective
regulatory authorities. It includes the
time it will take to answer the data
collectors’ questions and is the same
regardless of the facility type.
To calculate the estimate of the hours
per response, FDA will use the average
data collection duration for the same
facility types during the 2013–2014 data
collection. FDA estimates that it will
take the persons in charge of full service
restaurants and fast food restaurants 104
minutes (1.73 hours) and 82 minutes
(1.36 hours), respectfully, to accompany
the data collectors while they complete
Sections 1 and 3 of the form. In
comparison, for the 2013–2014 data
collection, the burden estimate was 106
minutes (1.76 hours) in full service
restaurants and 73 minutes (1.21 hours)
in fast food restaurants. FDA estimates
that it will take the program director (or
designated individual) of the respective
regulatory authority 30 minutes (0.5
hours) to answer the questions related to
Section 2 of the form. This burden
estimate is unchanged from the last data
collection. Hence, the total burden
estimate for a data collection in a full
service restaurant, including the both
the program director’s and the person in
charge’s responses, is 134 minutes (104
+ 30)(2.23 hours). The total burden
estimate for a data collection in a fast
food restaurant, including the both the
program director’s and the person in
charge’s responses, is 112 minutes 82 +
30) (1.86 hours).
Based on the number of entry refusals
from the 2013–2014 data collection, we
estimate a refusal rate of 2 percent. The
estimate of the time per non-respondent
is five minutes (0.08 hours) for the
person in charge to listen to the purpose
of the visit and provide a verbal refusal
of entry.
E:\FR\FM\11DEN1.SGM
11DEN1
Federal Register / Vol. 79, No. 238 / Thursday, December 11, 2014 / Notices
73599
TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1
Activity
Number of
respondents
Number of
responses
per
respondent
Total annual
responses
2017–2018 Data Collection (Fast Food Restaurants)—Completion of Sections 1 and
3.
2017–2018 Data Collection (Full Service
Restaurants)—Completion of Sections 1
and 3.
2017–2018 Data Collection-Completion of
Section 2—All Facility
Types.
2017–2018 Data Collection-Entry Refusals—
All Facility Types.
400
1
400
1.36 ...........
544
400
1
400
1.73 ...........
692
800
1
800
0.5 (30 minutes).
400
0.08 (5 minutes).
1.28
...............
1,637.28
Number of
nonrespondents
16
Number of
responses
per nonrespondent
Total annual
nonresponses
1
16
Total hours ............
1 There
The following reference has been
placed on display in the Division of
Dockets Management (see ADDRESSES)
and may be seen by interested persons
between 9 a.m. and 4 p.m., Monday
through Friday, and are available
electronically at https://
www.regulations.gov.
1. FDA Food Code. Available at:
https://www.fda.gov/Food/
GuidanceRegulation/
RetailFoodProtection/FoodCode/
default.htm.
Dated: December 5, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014–29065 Filed 12–10–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–P–0320]
mstockstill on DSK4VPTVN1PROD with NOTICES
Determination That PFIZERPEN
(Penicillin G Potassium) Injection, 1
Million Units/Vial, Was Not Withdrawn
From Sale for Reasons of Safety or
Effectiveness
Food and Drug Administration,
HHS.
ACTION:
Total hours
are no capital costs or operating and maintenance costs associated with this collection of information.
II. Reference
AGENCY:
Average
burden per
response
Notice.
The Food and Drug
Administration (FDA) has determined
that PFIZERPEN (penicillin G
potassium) Injection, 1 million units/
SUMMARY:
VerDate Sep<11>2014
19:07 Dec 10, 2014
Jkt 235001
vial, was not withdrawn from sale for
reasons of safety or effectiveness. This
determination will allow FDA to
approve abbreviated new drug
applications (ANDAs) for penicillin G
potassium injection, 1 million units/
vial, if all other legal and regulatory
requirements are met.
FOR FURTHER INFORMATION CONTACT:
Nikki Mueller, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6250,
Silver Spring, MD 20993–0002, 301–
796–3601.
SUPPLEMENTARY INFORMATION: In 1984,
Congress enacted the Drug Price
Competition and Patent Term
Restoration Act of 1984 (Pub. L. 98–417)
(the 1984 amendments), which
authorized the approval of duplicate
versions of drug products under an
ANDA procedure. ANDA applicants
must, with certain exceptions, show that
the drug for which they are seeking
approval contains the same active
ingredient in the same strength and
dosage form as the ‘‘listed drug,’’ which
is a version of the drug that was
previously approved. ANDA applicants
do not have to repeat the extensive
clinical testing otherwise necessary to
gain approval of a new drug application
(NDA).
The 1984 amendments include what
is now section 505(j)(7) of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C.
355(j)(7)), which requires FDA to
publish a list of all approved drugs.
FDA publishes this list as part of the
‘‘Approved Drug Products with
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Therapeutic Equivalence Evaluations,’’
which is known generally as the
‘‘Orange Book.’’ Under FDA regulations,
drugs are removed from the list if the
Agency withdraws or suspends
approval of the drug’s NDA or ANDA
for reasons of safety or effectiveness or
if FDA determines that the listed drug
was withdrawn from sale for reasons of
safety or effectiveness (21 CFR 314.162).
A person may petition the Agency to
determine, or the Agency may
determine on its own initiative, whether
a listed drug was withdrawn from sale
for reasons of safety or effectiveness.
This determination may be made at any
time after the drug has been withdrawn
from sale, but must be made prior to
approving an ANDA that refers to the
listed drug (21 CFR 314.161). FDA may
not approve an ANDA that does not
refer to a listed drug.
PFIZERPEN (penicillin G potassium)
Injection, 1 million units/vial, is the
subject of ANDA 60–657, held by Pfizer,
Inc., and initially approved on August
30, 1968. ANDA 60–657 is considered
the designated reference standard.
PFIZERPEN is indicated in the
treatment of serious infections caused
by susceptible strains of the designated
microorganisms in certain conditions
such as septicemia, pneumonia,
meningitis, anthrax, and listeria.
PFIZERPEN (penicillin G potassium)
Injection, 1 million units/vial, is
currently listed in the ‘‘Discontinued
Drug Product List’’ section of the Orange
Book. Lachman Consultant Services,
Inc., submitted a citizen petition dated
May 27, 2008 (Docket No. FDA–2008–
P–0320), under 21 CFR 10.30,
E:\FR\FM\11DEN1.SGM
11DEN1
Agencies
[Federal Register Volume 79, Number 238 (Thursday, December 11, 2014)]
[Notices]
[Pages 73596-73599]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-29065]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-2076]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Survey on the Occurrence of Foodborne Illness Risk
Factors in Selected Restaurant Facility Types
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on a survey entitled,
``Occurrence of Foodborne Illness Risk Factors in Selected Restaurant
Facility Types (2013-2022).''
DATES: Submit either electronic or written comments on the collection
of information by February 9, 2015.
ADDRESSES: Submit electronic comments on the collection of information
to https://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
[[Page 73597]]
Survey on the Occurrence of Foodborne Illness Risk Factors in Selected
Restaurant Facility Types (2013-2022) (OMB Control Number 0910-0744)
I. Background
In 2013-2014, the U.S. Food and Drug Administration (FDA) initiated
a study in two foodservice facility types: Full service and fast food
restaurants. The study will span 10 years in its entirety and aims to:
Assist FDA with developing retail food safety initiatives
and policies focused on the control of foodborne illness risk factors--
preparation practices and employee behaviors most commonly reported to
the Centers for Disease Control and Prevention as contributing factors
to foodborne illness outbreaks at the retail level. (i.e. food from
unsafe sources, poor personal hygiene, inadequate cooking, improper
holding/time and temperature, and contaminated equipment/cross-
contamination);
Identify retail food safety work plan priorities and
allocate resources to enhance retail food safety nationwide;
Track changes in the occurrence of foodborne illness risk
factors in retail and foodservice establishments over time; and
Inform recommendations to the retail and foodservice
industry and state, local, tribal, and territorial regulatory
professionals on reducing the occurrence of foodborne illness risk
factors.
Table 1--Description of the Facility Types Included in the Survey
------------------------------------------------------------------------
Facility type Description
------------------------------------------------------------------------
Full Service Restaurants..... A restaurant where customers place their
order at their table, are served their
meal at the table, receive the service
of the wait staff, and pay at the end of
the meal.
Fast Food Restaurants........ A restaurant that is not a full service
restaurant This includes restaurants
commonly referred to as quick service
restaurants and fast casual restaurants.
------------------------------------------------------------------------
The statutory basis for FDA conducting this study is derived from
the Public Health Service Act (42 U.S.C. 243, section 311(a)).
Responsibility for carrying out the provisions of the Act relative to
food protection was transferred to the Commissioner of Food and Drugs
in 1968 (21 CFR 5.10(a)(2) and (4)). Additionally, the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 301 et seq) and the Economy Act (31
U.S.C. 1535) require FDA to provide assistance to other Federal, state,
and local government bodies.
The objectives of the study are to:
Identify the foodborne illness risk factors that are in
most need of priority attention during each data collection period;
Track trends in the occurrence of foodborne illness risk
factors over time;
Examine potential correlations between operational
characteristics of food establishments and the control of foodborne
illness risk factors;
Examine potential correlations between elements within
regulatory retail food protection programs and the control of foodborne
illness risk factors; and
Evaluate the impact of industry food safety management
systems in controlling the occurrence of foodborne illness risk
factors.
The data from the 2013-2014 information collection in restaurants
is currently being analyzed by FDA. A report summarizing the findings
is expected to be released in 2015. In order to analyze trends, FDA is
proposing to conduct two additional data collections in 2017-2018 and
2021-2022 using the same methodology employed in the 2013-2014 data
collection. This methodology is described as follows.
In order to obtain a sufficient number of observations to conduct
statistically significant analysis, FDA will conduct approximately 400
data collections in each restaurant facility type during each data
collection period. This sample size has been calculated to provide for
sufficient observations to be 95 percent confident that the compliance
percentage is within 5 percent of the true compliance percentage.
A geographical information system database containing a listing of
businesses throughout the United States will be used as the
establishment inventory for the data collections. FDA will sample
establishments from the inventory based on the descriptions in table 1.
FDA does not intend to sample operations that handle only prepackaged
food items or conduct low risk food preparation activities. The FDA
Food Code contains a grouping of establishments by risk, based on the
type of food preparation that is normally conducted within the
operation (Ref. 1). The intent is to sample establishments that fall
under risk categories 2 through 4.
FDA has approximately 25 Regional Retail Food Specialists
(Specialists) who will serve as the data collectors for the 10 year
study. The Specialists are geographically dispersed throughout the
United States and possess technical expertise in retail food safety and
a solid understanding of the operations within each of the facility
types to be surveyed. The Specialists are also standardized by FDA's
Center for Food Safety and Applied Nutrition personnel in the
application and interpretation of the FDA Food Code (Ref. 1).
Sampling zones will be established which are equal to the 150 mile
radius around a Specialist's home location. The sample will be selected
randomly from among all eligible establishments located within these
sampling zones. The Specialists are generally located in major
metropolitan areas (i.e. population centers) across the contiguous
United States. Population centers usually contain a large concentration
of the establishments FDA intends to sample. Sampling from the 150 mile
radius sampling zones around the Specialists' home locations provides
three advantages to the study:
1. It provides a cross section of urban and rural areas from which
to sample the eligible establishments.
2. It represents a mix of small, medium, and large regulatory
entities having jurisdiction over the eligible establishments.
3. It reduces overnight travel and therefore reduces travel costs
incurred by the Agency to collect data.
The sample for each data collection period will be evenly
distributed among Specialists. Given that participation in the study by
industry is voluntary and the status of any given randomly selected
establishment is subject to change, substitute establishments will be
selected for each Specialist for cases where the restaurant facility is
misclassified, closed, or otherwise unavailable, unable, or unwilling
to participate.
Prior to conducting the data collection, Specialists will contact
the state or local jurisdiction that has regulatory responsibility for
conducting retail food inspections for the selected establishment. The
Specialist will verify
[[Page 73598]]
with the jurisdiction that the facility has been properly classified
for the purposes of the study and is still in operation. The Specialist
will also ascertain whether the selected facility is under legal notice
from the state or local regulatory authority. If the selected facility
is under legal notice, the Specialist will not conduct a data
collection, and a substitute establishment will be used. An invitation
will be extended to the state or local regulatory authority to
accompany the Specialist on the data collection visit.
A standard form will be used by the Specialists during each data
collection. The form is divided into three sections: Section 1--
''Establishment Information;'' Section 2--''Regulatory Authority
Information;'' and Section 3--''Foodborne Illness Risk Factor and Food
Safety Management System Assessment.'' The information in Section 1--
``Establishment Information'' of the form will be obtained during an
interview with the establishment owner or person in charge by the
Specialist and will include a standard set of questions.
The information in Section 2--``Regulatory Authority Information''
will be obtained during an interview with the program director of the
state or local jurisdiction that has regulatory responsibility for
conducting inspections for the selected establishment. Section 3
includes three parts: Part A for tabulating the Specialists'
observations of the food employees' behaviors and practices in limiting
contamination, proliferation, and survival of food safety hazards; Part
B for assessing the food safety management being implemented by the
facility; and Part C for assessing the frequency and extent of food
employee hand washing. The information in Part A will be collected from
the Specialists' direct observations of food employee behaviors and
practices. Infrequent, nonstandard questions may be asked by the
Specialists if clarification is needed on the food safety procedure or
practice being observed. The information in Part B will be collected by
making direct observations and asking follow up questions of facility
management to obtain information on the extent to which the food
establishment has developed and implemented food safety management
systems. The information in Part C will be collected by making direct
observations of food employee hand washing. No questions will be asked
in the completion of Section 3, Part C of the form.
FDA will collect the following information associated with the
establishment's identity: Establishment name, street address, city,
state, zip code, county, industry segment, and facility type. The
establishment identifying information is collected to ensure the survey
is not duplicative. The establishment identifying information is
collected to ensure the data collections are not duplicative. Other
information related to the nature of the operation, such as seating
capacity and number of employees per shift, will also be collected.
Data will be consolidated and reported in a manner that does not reveal
the identity of any establishment included in the study.
FDA is working with the National Center for Food Protection and
Defense to develop a Web-based platform in FoodSHIELD to collect,
store, and analyze data for the Retail Risk Factor Study. Once
developed, this platform will be accessible to state, local,
territorial, and tribal regulatory jurisdictions to collect data
relevant to their own risk factor studies. FDA is currently
transitioning from the manual entry of data to the use of hand-held
technology. FDA will be pilot testing the use of hand-held technology
during its 2015-2016 risk factor study data collection in institutional
foodservice and retail food stores, with the goal to have it fully
implemented for the 2017-2018 data collection in restaurants. When a
data collector is assigned a specific establishment, he or she will
conduct the data collection and enter the information into the Web-
based data platform. The interface will support the manual entering of
data, as well as the ability to upload a fillable PDF.
The burden for the 2017-2018 data collection is as follows. For
each data collection, the respondents will include: (1) The person in
charge of the selected restaurant facility (whether it be a fast food
or full service restaurant); and (2) the program director (or
designated individual) of the respective regulatory authority. In order
to provide the sufficient number of observations needed to conduct a
statistically significant analysis of the data, FDA has determined that
the same number of data collections will be required in each of the two
restaurant facility types as was required in the 2013-2014 data
collection (i.e. 400). Therefore, the total number of responses for
restaurants will be 1,600 (400 data collections x 2 facility types x 2
respondents per data collection).
The burden associated with the completion of Sections 1 and 3 of
the form is specific to the persons in charge of the selected
facilities. It includes the time it will take the person in charge to
accompany the data collector as he or she completes Sections 1 and 3 of
the form. The burden related to the completion of Section 2 of the form
is specific to the program directors (or designated individuals) of the
respective regulatory authorities. It includes the time it will take to
answer the data collectors' questions and is the same regardless of the
facility type.
To calculate the estimate of the hours per response, FDA will use
the average data collection duration for the same facility types during
the 2013-2014 data collection. FDA estimates that it will take the
persons in charge of full service restaurants and fast food restaurants
104 minutes (1.73 hours) and 82 minutes (1.36 hours), respectfully, to
accompany the data collectors while they complete Sections 1 and 3 of
the form. In comparison, for the 2013-2014 data collection, the burden
estimate was 106 minutes (1.76 hours) in full service restaurants and
73 minutes (1.21 hours) in fast food restaurants. FDA estimates that it
will take the program director (or designated individual) of the
respective regulatory authority 30 minutes (0.5 hours) to answer the
questions related to Section 2 of the form. This burden estimate is
unchanged from the last data collection. Hence, the total burden
estimate for a data collection in a full service restaurant, including
the both the program director's and the person in charge's responses,
is 134 minutes (104 + 30)(2.23 hours). The total burden estimate for a
data collection in a fast food restaurant, including the both the
program director's and the person in charge's responses, is 112 minutes
82 + 30) (1.86 hours).
Based on the number of entry refusals from the 2013-2014 data
collection, we estimate a refusal rate of 2 percent. The estimate of
the time per non-respondent is five minutes (0.08 hours) for the person
in charge to listen to the purpose of the visit and provide a verbal
refusal of entry.
[[Page 73599]]
Table 2--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Number of
Number of responses Total annual Number of responses Total annual Average burden per
Activity respondents per responses non- per non- non- response Total hours
respondent respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
2017-2018 Data Collection (Fast 400 1 400 ............ ............ ............ 1.36.............. 544
Food Restaurants)_Completion of
Sections 1 and 3.
2017-2018 Data Collection (Full 400 1 400 ............ ............ ............ 1.73.............. 692
Service Restaurants)_Completion
of Sections 1 and 3.
2017-2018 Data Collection- 800 1 800 ............ ............ ............ 0.5 (30 minutes).. 400
Completion of Section 2_All
Facility Types.
2017-2018 Data Collection-Entry ............ ............ ............ 16 1 16 0.08 (5 minutes).. 1.28
Refusals_All Facility Types.
-----------------------------------------------------------------------------------------------------------------------
Total hours................. ............ ............ ............ ............ ............ ............ .................. 1,637.28
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
II. Reference
The following reference has been placed on display in the Division
of Dockets Management (see ADDRESSES) and may be seen by interested
persons between 9 a.m. and 4 p.m., Monday through Friday, and are
available electronically at https://www.regulations.gov.
1. FDA Food Code. Available at: https://www.fda.gov/Food/GuidanceRegulation/RetailFoodProtection/FoodCode/default.htm.
Dated: December 5, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014-29065 Filed 12-10-14; 8:45 am]
BILLING CODE 4164-01-P